» Articles » PMID: 33235916

Stimulation of Epidermal Hyperplasia and Tumorigenesis by Resident P16-expressing Cells

Overview
Journal Mol Cell Oncol
Specialty Oncology
Date 2020 Nov 25
PMID 33235916
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

p16 (CDKN2A) is a central tumor-suppressor and activator of senescence. We recently found that prolonged expression of p16 in epidermal cells induces hyperplasia and dysplasia through Wnt-mediated stimulation of neighboring keratinocytes. The study suggests a pro-tumorigenic function of p16 in early epidermal lesions, which could potentially be targeted by senolytic therapy.

Citing Articles

Multiple Myeloma Cells Alter Adipogenesis, Increase Senescence-Related and Inflammatory Gene Transcript Expression, and Alter Metabolism in Preadipocytes.

Fairfield H, Costa S, Falank C, Farrell M, Murphy C, DAmico A Front Oncol. 2021; 10:584683.

PMID: 33680918 PMC: 7930573. DOI: 10.3389/fonc.2020.584683.

References
1.
He S, Sharpless N . Senescence in Health and Disease. Cell. 2017; 169(6):1000-1011. PMC: 5643029. DOI: 10.1016/j.cell.2017.05.015. View

2.
Coppe J, Rodier F, Patil C, Freund A, Desprez P, Campisi J . Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype. J Biol Chem. 2011; 286(42):36396-403. PMC: 3196093. DOI: 10.1074/jbc.M111.257071. View

3.
Azazmeh N, Assouline B, Winter E, Ruppo S, Nevo Y, Maly A . Chronic expression of p16 in the epidermis induces Wnt-mediated hyperplasia and promotes tumor initiation. Nat Commun. 2020; 11(1):2711. PMC: 7264228. DOI: 10.1038/s41467-020-16475-3. View

4.
van Deursen J . Senolytic therapies for healthy longevity. Science. 2019; 364(6441):636-637. PMC: 6816502. DOI: 10.1126/science.aaw1299. View

5.
Baker D, Childs B, Durik M, Wijers M, Sieben C, Zhong J . Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature. 2016; 530(7589):184-9. PMC: 4845101. DOI: 10.1038/nature16932. View